Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

William Blair Initiates Coverage On MiNK Therapeutics with Outperform Rating

William Blair analyst Matt Phipps initiates coverage on MiNK Therapeutics (NASDAQ:INKT) with a Outperform rating.

byBenzinga Newsdesk

November 9, 2021

1 minute read

William Blair analyst Matt Phipps initiates coverage on MiNK Therapeutics (NASDAQ:INKT) with a Outperform rating.

Diana Shipping: Q4 Earnings Insights

By Benzinga Insights

Today, 2:17 PM

Diana Shipping (NYSE:DSX) reported its Q4 earnings results on Friday, February 25, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

DSX

Wall Street’s Most Accurate Analysts Say Hold These 2 Consumer Stocks With Over 6% Dividend Yields

By Lisa Levin

Today, 2:17 PM

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

BIG